194 related articles for article (PubMed ID: 27699247)
1. PKA regulatory subunit 1A inactivating mutation induces serotonin signaling in primary pigmented nodular adrenal disease.
Bram Z; Louiset E; Ragazzon B; Renouf S; Wils J; Duparc C; Boutelet I; Rizk-Rabin M; Libé R; Young J; Carson D; Vantyghem MC; Szarek E; Martinez A; Stratakis CA; Bertherat J; Lefebvre H
JCI Insight; 2016 Sep; 1(15):e87958. PubMed ID: 27699247
[TBL] [Abstract][Full Text] [Related]
2. Illicit Upregulation of Serotonin Signaling Pathway in Adrenals of Patients With High Plasma or Intra-Adrenal ACTH Levels.
Le Mestre J; Duparc C; Reznik Y; Bonnet-Serrano F; Touraine P; Chabre O; Young J; Suzuki M; Sibony M; Gobet F; Stratakis CA; Raverot G; Bertherat J; Lefebvre H; Louiset E
J Clin Endocrinol Metab; 2019 Nov; 104(11):4967-4980. PubMed ID: 31074783
[TBL] [Abstract][Full Text] [Related]
3. Mutations of the PRKAR1A gene in Cushing's syndrome due to sporadic primary pigmented nodular adrenocortical disease.
Groussin L; Jullian E; Perlemoine K; Louvel A; Leheup B; Luton JP; Bertagna X; Bertherat J
J Clin Endocrinol Metab; 2002 Sep; 87(9):4324-9. PubMed ID: 12213893
[TBL] [Abstract][Full Text] [Related]
4. PRKAR1A mutations in primary pigmented nodular adrenocortical disease.
Cazabat L; Ragazzon B; Groussin L; Bertherat J
Pituitary; 2006; 9(3):211-9. PubMed ID: 17036196
[TBL] [Abstract][Full Text] [Related]
5. mTOR pathway is activated by PKA in adrenocortical cells and participates in vivo to apoptosis resistance in primary pigmented nodular adrenocortical disease (PPNAD).
de Joussineau C; Sahut-Barnola I; Tissier F; Dumontet T; Drelon C; Batisse-Lignier M; Tauveron I; Pointud JC; Lefrançois-Martinez AM; Stratakis CA; Bertherat J; Val P; Martinez A
Hum Mol Genet; 2014 Oct; 23(20):5418-28. PubMed ID: 24865460
[TBL] [Abstract][Full Text] [Related]
6. Protein kinase A subunit expression is altered in Bloom syndrome fibroblasts and the BLM protein is increased in adrenocortical hyperplasias: inverse findings for BLM and PRKAR1A.
Heyerdahl SL; Boikos S; Horvath A; Giatzakis C; Bossis I; Stratakis CA
Horm Metab Res; 2008 Jun; 40(6):391-7. PubMed ID: 18401830
[TBL] [Abstract][Full Text] [Related]
7. Detection of somatic beta-catenin mutations in primary pigmented nodular adrenocortical disease (PPNAD).
Tadjine M; Lampron A; Ouadi L; Horvath A; Stratakis CA; Bourdeau I
Clin Endocrinol (Oxf); 2008 Sep; 69(3):367-73. PubMed ID: 18419788
[TBL] [Abstract][Full Text] [Related]
8. Molecular cloning, chromosomal localization of human peripheral-type benzodiazepine receptor and PKA regulatory subunit type 1A (PRKAR1A)-associated protein PAP7, and studies in PRKAR1A mutant cells and tissues.
Liu J; Matyakhina L; Han Z; Sandrini F; Bei T; Stratakis CA; Papadopoulos V
FASEB J; 2003 Jun; 17(9):1189-91. PubMed ID: 12692076
[TBL] [Abstract][Full Text] [Related]
9. The paradoxical increase in cortisol secretion induced by dexamethasone in primary pigmented nodular adrenocortical disease involves a glucocorticoid receptor-mediated effect of dexamethasone on protein kinase A catalytic subunits.
Louiset E; Stratakis CA; Perraudin V; Griffin KJ; Libé R; Cabrol S; Fève B; Young J; Groussin L; Bertherat J; Lefebvre H
J Clin Endocrinol Metab; 2009 Jul; 94(7):2406-13. PubMed ID: 19383776
[TBL] [Abstract][Full Text] [Related]
10. Regulation of steroidogenesis in a primary pigmented nodular adrenocortical disease-associated adenoma leading to virilization and subclinical Cushing's syndrome.
Hofland J; de Herder WW; Derks L; Hofland LJ; van Koetsveld PM; de Krijger RR; van Nederveen FH; Horvath A; Stratakis CA; de Jong FH; Feelders RA
Eur J Endocrinol; 2013 Jan; 168(1):67-74. PubMed ID: 23065993
[TBL] [Abstract][Full Text] [Related]
11. c-KIT oncogene expression in PRKAR1A-mutant adrenal cortex.
Nadella K; Faucz FR; Stratakis CA
Endocr Relat Cancer; 2020 Oct; 27(10):591-599. PubMed ID: 32738126
[TBL] [Abstract][Full Text] [Related]
12. Depletion of type IA regulatory subunit (RIalpha) of protein kinase A (PKA) in mammalian cells and tissues activates mTOR and causes autophagic deficiency.
Mavrakis M; Lippincott-Schwartz J; Stratakis CA; Bossis I
Hum Mol Genet; 2006 Oct; 15(19):2962-71. PubMed ID: 16963469
[TBL] [Abstract][Full Text] [Related]
13. A large family with Carney complex caused by the S147G PRKAR1A mutation shows a unique spectrum of disease including adrenocortical cancer.
Anselmo J; Medeiros S; Carneiro V; Greene E; Levy I; Nesterova M; Lyssikatos C; Horvath A; Carney JA; Stratakis CA
J Clin Endocrinol Metab; 2012 Feb; 97(2):351-9. PubMed ID: 22112814
[TBL] [Abstract][Full Text] [Related]
14. Familial isolated primary pigmented nodular adrenocortical disease associated with a novel low penetrance PRKAR1A gene splice site mutation.
Storr HL; Metherell LA; Dias R; Savage MO; Rasmussen AK; Clark AJ; Main KM
Horm Res Paediatr; 2010; 73(2):115-9. PubMed ID: 20190548
[TBL] [Abstract][Full Text] [Related]
15. Adrenal pathophysiology: lessons from the Carney complex.
Groussin L; Cazabat L; René-Corail F; Jullian E; Bertherat J
Horm Res; 2005; 64(3):132-9. PubMed ID: 16192737
[TBL] [Abstract][Full Text] [Related]
16. MicroRNA signature of primary pigmented nodular adrenocortical disease: clinical correlations and regulation of Wnt signaling.
Iliopoulos D; Bimpaki EI; Nesterova M; Stratakis CA
Cancer Res; 2009 Apr; 69(8):3278-82. PubMed ID: 19351815
[TBL] [Abstract][Full Text] [Related]
17. Primary pigmented nodular adrenocortical disease (PPNAD): single centre experience.
Memon SS; Thakkar K; Patil V; Jadhav S; Lila AR; Fernandes G; Bandgar TR; Shah NS
J Pediatr Endocrinol Metab; 2019 Apr; 32(4):391-397. PubMed ID: 30875328
[TBL] [Abstract][Full Text] [Related]
18. Molecular analysis of the cyclic AMP-dependent protein kinase A (PKA) regulatory subunit 1A (PRKAR1A) gene in patients with Carney complex and primary pigmented nodular adrenocortical disease (PPNAD) reveals novel mutations and clues for pathophysiology: augmented PKA signaling is associated with adrenal tumorigenesis in PPNAD.
Groussin L; Kirschner LS; Vincent-Dejean C; Perlemoine K; Jullian E; Delemer B; Zacharieva S; Pignatelli D; Carney JA; Luton JP; Bertagna X; Stratakis CA; Bertherat J
Am J Hum Genet; 2002 Dec; 71(6):1433-42. PubMed ID: 12424709
[TBL] [Abstract][Full Text] [Related]
19. PRKAR1A Mutations and protein kinase A interactions with other signaling pathways in the adrenal cortex.
Robinson-White A; Meoli E; Stergiopoulos S; Horvath A; Boikos S; Bossis I; Stratakis CA
J Clin Endocrinol Metab; 2006 Jun; 91(6):2380-8. PubMed ID: 16569736
[TBL] [Abstract][Full Text] [Related]
20. Association of the M1V PRKAR1A mutation with primary pigmented nodular adrenocortical disease in two large families.
Pereira AM; Hes FJ; Horvath A; Woortman S; Greene E; Bimpaki E; Alatsatianos A; Boikos S; Smit JW; Romijn JA; Nesterova M; Stratakis CA
J Clin Endocrinol Metab; 2010 Jan; 95(1):338-42. PubMed ID: 19915019
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
